Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats

S. L. Shepheard, D. J. Williamson, John Williams, R. G. Hill, R. J. Hargreaves

Research output: Contribution to journalArticle

152 Citations (Scopus)

Abstract

Dural plasma extravasation produced by electrical stimulation of the trigeminal ganglion was measured in rats and the concomitant expression of c-fos mRNA produced in the trigeminal nucleus caudalis (NtV) was measured using in situ hybridization techniques. The non-peptide NK1 receptor selective antagonist CP-99,994 (1-3000 μg kg-1) and the 5HT1D receptor agonist sumatriptan (1-1000 μg kg-1) reduced dural plasma extravasation dose-dependently with ID50s of 52 μg kg-1 and 30 μg kg-1 respectively. CP-99,994 (1000 μg kg-1), a compound known to have good brain penetration, decreased c-fos mRNA expression in the NtV by 37 ±7% without disruption of the blood brain barrier (BBB). Sumatriptan (1000 μg kg-1), known to be poorly brain penetrant, had no significant effect on c-fos mRNA expression in the NtV unless the BBB was disrupted by infusion of a hyperosmolar mannitol solution after which sumatriptan decreased c-fos mRNA expression by 65 ±11%. The results suggest that brain penetrant NK1 receptor antagonists may have anti-migraine effects peripherally through blockade of dural extravasation and centrally by inhibition of nociceptive pathways. Furthermore the data indicates that the anti-migraine action of sumatriptan must be predominantly peripherally mediated, be it via inhibition of plasma extravasation or direct vasoconstriction, since it had little effect on the activation of neurones in the NtV unless the BBB was disrupted.

Original languageEnglish (US)
Pages (from-to)255-261
Number of pages7
JournalNeuropharmacology
Volume34
Issue number3
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Trigeminal Nuclei
Sumatriptan
Dura Mater
Blood-Brain Barrier
Messenger RNA
Migraine Disorders
Brain
Trigeminal Ganglion
Mannitol
Vasoconstriction
Electric Stimulation
In Situ Hybridization
Neurons
3-(2-methoxybenzylamino)-2-phenylpiperidine

Keywords

  • 994
  • c-fos mRNA
  • CP-99
  • dural extravasation
  • migraine
  • sumatriptan

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology
  • Drug Discovery

Cite this

Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. / Shepheard, S. L.; Williamson, D. J.; Williams, John; Hill, R. G.; Hargreaves, R. J.

In: Neuropharmacology, Vol. 34, No. 3, 1995, p. 255-261.

Research output: Contribution to journalArticle

@article{5929050bd1be4717b882e38f89b57b18,
title = "Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats",
abstract = "Dural plasma extravasation produced by electrical stimulation of the trigeminal ganglion was measured in rats and the concomitant expression of c-fos mRNA produced in the trigeminal nucleus caudalis (NtV) was measured using in situ hybridization techniques. The non-peptide NK1 receptor selective antagonist CP-99,994 (1-3000 μg kg-1) and the 5HT1D receptor agonist sumatriptan (1-1000 μg kg-1) reduced dural plasma extravasation dose-dependently with ID50s of 52 μg kg-1 and 30 μg kg-1 respectively. CP-99,994 (1000 μg kg-1), a compound known to have good brain penetration, decreased c-fos mRNA expression in the NtV by 37 ±7{\%} without disruption of the blood brain barrier (BBB). Sumatriptan (1000 μg kg-1), known to be poorly brain penetrant, had no significant effect on c-fos mRNA expression in the NtV unless the BBB was disrupted by infusion of a hyperosmolar mannitol solution after which sumatriptan decreased c-fos mRNA expression by 65 ±11{\%}. The results suggest that brain penetrant NK1 receptor antagonists may have anti-migraine effects peripherally through blockade of dural extravasation and centrally by inhibition of nociceptive pathways. Furthermore the data indicates that the anti-migraine action of sumatriptan must be predominantly peripherally mediated, be it via inhibition of plasma extravasation or direct vasoconstriction, since it had little effect on the activation of neurones in the NtV unless the BBB was disrupted.",
keywords = "994, c-fos mRNA, CP-99, dural extravasation, migraine, sumatriptan",
author = "Shepheard, {S. L.} and Williamson, {D. J.} and John Williams and Hill, {R. G.} and Hargreaves, {R. J.}",
year = "1995",
doi = "10.1016/0028-3908(94)00153-J",
language = "English (US)",
volume = "34",
pages = "255--261",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats

AU - Shepheard, S. L.

AU - Williamson, D. J.

AU - Williams, John

AU - Hill, R. G.

AU - Hargreaves, R. J.

PY - 1995

Y1 - 1995

N2 - Dural plasma extravasation produced by electrical stimulation of the trigeminal ganglion was measured in rats and the concomitant expression of c-fos mRNA produced in the trigeminal nucleus caudalis (NtV) was measured using in situ hybridization techniques. The non-peptide NK1 receptor selective antagonist CP-99,994 (1-3000 μg kg-1) and the 5HT1D receptor agonist sumatriptan (1-1000 μg kg-1) reduced dural plasma extravasation dose-dependently with ID50s of 52 μg kg-1 and 30 μg kg-1 respectively. CP-99,994 (1000 μg kg-1), a compound known to have good brain penetration, decreased c-fos mRNA expression in the NtV by 37 ±7% without disruption of the blood brain barrier (BBB). Sumatriptan (1000 μg kg-1), known to be poorly brain penetrant, had no significant effect on c-fos mRNA expression in the NtV unless the BBB was disrupted by infusion of a hyperosmolar mannitol solution after which sumatriptan decreased c-fos mRNA expression by 65 ±11%. The results suggest that brain penetrant NK1 receptor antagonists may have anti-migraine effects peripherally through blockade of dural extravasation and centrally by inhibition of nociceptive pathways. Furthermore the data indicates that the anti-migraine action of sumatriptan must be predominantly peripherally mediated, be it via inhibition of plasma extravasation or direct vasoconstriction, since it had little effect on the activation of neurones in the NtV unless the BBB was disrupted.

AB - Dural plasma extravasation produced by electrical stimulation of the trigeminal ganglion was measured in rats and the concomitant expression of c-fos mRNA produced in the trigeminal nucleus caudalis (NtV) was measured using in situ hybridization techniques. The non-peptide NK1 receptor selective antagonist CP-99,994 (1-3000 μg kg-1) and the 5HT1D receptor agonist sumatriptan (1-1000 μg kg-1) reduced dural plasma extravasation dose-dependently with ID50s of 52 μg kg-1 and 30 μg kg-1 respectively. CP-99,994 (1000 μg kg-1), a compound known to have good brain penetration, decreased c-fos mRNA expression in the NtV by 37 ±7% without disruption of the blood brain barrier (BBB). Sumatriptan (1000 μg kg-1), known to be poorly brain penetrant, had no significant effect on c-fos mRNA expression in the NtV unless the BBB was disrupted by infusion of a hyperosmolar mannitol solution after which sumatriptan decreased c-fos mRNA expression by 65 ±11%. The results suggest that brain penetrant NK1 receptor antagonists may have anti-migraine effects peripherally through blockade of dural extravasation and centrally by inhibition of nociceptive pathways. Furthermore the data indicates that the anti-migraine action of sumatriptan must be predominantly peripherally mediated, be it via inhibition of plasma extravasation or direct vasoconstriction, since it had little effect on the activation of neurones in the NtV unless the BBB was disrupted.

KW - 994

KW - c-fos mRNA

KW - CP-99

KW - dural extravasation

KW - migraine

KW - sumatriptan

UR - http://www.scopus.com/inward/record.url?scp=0028941078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028941078&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(94)00153-J

DO - 10.1016/0028-3908(94)00153-J

M3 - Article

C2 - 7630480

AN - SCOPUS:0028941078

VL - 34

SP - 255

EP - 261

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 3

ER -